skip to Main Content

MaRS Innovation establishes co-managed fund with Johnson & Johnson

MaRS Innovation (MI) has signed a co-funding agreement with the Johnson & Johnson Corporate Office of Science and Technology to capitalize and accelerate the use of Toronto-based life sciences technologies during the early stages of pharmaceutical and medical device development.

The Translational Innovation Partnership Program (TIPP) is the first co-funding agreement of its kind for MI.

Continue Reading
Back To Top